Jette Lautrup Fredriksen

Jette Lautrup Fredriksen

Clinical Professor

Member of:

  • Neurology

ORCID: 0000-0003-1661-7438

Publication year:
All
1 - 5 out of 5Page size: 10
  1. 2009
  2. Published

    MRI as an outcome in multiple sclerosis clinical trials

    Sormani, M. P., Filippi, M., De Stefano, N., Ebers, G., Daumer, M., Fredriksen, Jette Lautrup & MAGNIMS Steering Committee, M. S. C., 1 Dec 2009, In: Neurology. 73, 22, p. 1932; author reply 1932-3

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial

    Kappos, L., Freedman, M. S., Polman, C. H., Edan, G., Hartung, H., Miller, D. H., Montalbán, X., Barkhof, F., Radü, E., Metzig, C., Bauer, L., Lanius, V., Sandbrink, R., Pohl, C., Fredriksen, Jette Lautrup & BENEFIT Study Group, B. S. G., 1 Nov 2009, In: Lancet Neurology Network. 8, 11, p. 987-97 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Management of optic neuritis and impact of clinical trials: an international survey

    Biousse, V., Calvetti, O., Drews-Botsch, C. D., Atkins, E. J., Sathornsumetee, B., Newman, N. J., Optic Neuritis Survey Group, Fredriksen, Jette Lautrup & Optic Neuritis Survey Group, O. N. S. G., 15 Jan 2009, In: Journal of the Neurological Sciences. 276, 1-2, p. 69-74 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Oral fingolimod (FTY720) in multiple sclerosis: two-year results of a phase II extension study

    O'Connor, P., Comi, G., Montalban, X., Antel, J., Radue, E. W., de Vera, A., Pohlmann, H., Kappos, L., Fredriksen, Jette Lautrup & FTY720 D2201 Study Group, F. D. S. G., 6 Jan 2009, In: Neurology. 72, 1, p. 73-9 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

    Comi, G., Martinelli, V., Rodegher, M., Moiola, L., Bajenaru, O., Carra, A., Elovaara, I., Fazekas, F., Hartung, H. P., Hillert, J., King, J., Komoly, S., Lubetzki, C., Montalban, X., Myhr, K. M., Ravnborg, M., Rieckmann, P., Wynn, D., Young, C., Filippi, M. & 2 others, Fredriksen, Jette Lautrup & PreCISe study group, P. S. G., 2009, In: Lancet. 374, 9700, p. 1503-1511 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 982687